Skip to main content
SEP ANALYTICAL (SHANGHAI) CO., LTD. logo

SEP ANALYTICAL (SHANGHAI) CO., LTD. — Investor Relations & Filings

Ticker · 301228 ISIN · CNE1000057C6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 609 across all filing types
Latest filing 2024-01-31 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301228

About SEP ANALYTICAL (SHANGHAI) CO., LTD.

https://www.sepchina.cn

SEP Analytical (Shanghai) Co., Ltd. specializes in the provision of high-performance chromatography consumables and analytical laboratory equipment. The company’s core portfolio includes high-performance liquid chromatography (HPLC) columns, gas chromatography (GC) columns, and solid-phase extraction (SPE) products. It also supplies a wide range of laboratory essentials such as vials, caps, and syringe filters. These products are engineered to support precise chemical analysis across various sectors, including pharmaceutical research, environmental testing, and food safety. The company focuses on delivering reliable separation solutions that enhance the sensitivity and reproducibility of analytical workflows. Through continuous technical innovation, SEP Analytical provides specialized tools designed to meet the rigorous demands of modern laboratory environments and complex sample matrices.

Recent filings

Filing Released Lang Actions
关于与专业投资机构共同投资私募股权投资基金的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a private equity investment fund involving the company. It details the investment overview, fund registration, and regulatory filing status. The text is relatively short (937 characters) and does not contain financial statements or detailed financial data. It is an update on financing activity and fund formation progress rather than a full financial report or regulatory certification. Therefore, it fits best under Capital/Financing Update (CAP).
2024-01-31 Chinese
2023年年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2023 annual performance forecast (业绩预告) from a company, providing estimated net profit and revenue figures for the full year 2023. It explicitly states that the forecast is preliminary, unaudited, and that detailed financial data will be disclosed in the 2023 annual report. The document is short (819 characters) and serves as an announcement of expected financial results rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. FY 2023
2024-01-30 Chinese
关于回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, total amount spent, and compliance with regulatory guidelines. It references the company's board meeting approval of the repurchase plan and ongoing disclosure obligations. The document is short (1246 characters) and focuses on the update of share buyback activity rather than a full financial report or other types of filings. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2024-01-02 Chinese
海通证券股份有限公司关于实朴检测技术（上海）股份有限公司2023年度持续督导的培训情况报告
Regulatory Filings Classification · 95% confidence The document is a report from Haitong Securities regarding the 2023 annual continuous supervision training for a company related to its IPO and listing. It details the training session held on December 22, 2023, including participants, content, and summary. The document is short (940 characters) and focuses on a regulatory training event rather than financial results, management changes, or shareholder votes. It is not an Annual Report, Interim Report, Earnings Release, or any financial statement. It is also not a notice of voting results or a proxy statement. The document is a formal report on a regulatory compliance training activity related to IPO supervision, which fits best under Regulatory Filings (RNS) as it does not match any other specific category and is a compliance-related announcement.
2023-12-27 Chinese
关于与专业投资机构共同投资私募股权投资基金的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of an investment by the company in a private equity fund. It details the investment amount, the registration of the fund, and related business license information. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about financing activity, specifically about the company's investment in a fund. This fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2023-12-25 Chinese
关于与专业投资机构共同设立私募股权投资基金的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about its plan to co-establish a private equity investment fund with professional investment institutions. It includes extensive information about the fund's structure, partners, investment scope, management, rights and obligations, risk factors, and other related details. The document is not a financial report, earnings release, or management discussion but rather an announcement of a capital investment and financing activity. It does not contain financial statements or quarterly/yearly results but focuses on the establishment and terms of a private equity fund. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2023-12-07 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.